Continuing Medical Education Information (CME)
This activity is supported by independent educational grants from commercial interests. Complete information will be provided to participants prior to the activity.
This activity is intended for all surgeons and other healthcare professionals who are involved in the treatment of patients with cancer.
Overall Educational Objectives
- Summarize recent updates and current controversies in the multidisciplinary management of patients with breast cancer, melanoma, sarcoma, pancreas and hepatobiliary malignancies, thyroid, gastric cancer, colorectal cancer, genomics, and peritoneal surface malignancies.
- Review and employ treatment methods and procedures from 2018 practice changing studies in breast, melanoma, sarcoma, pancreas and hepatobiliary malignancies, gastric cancer, colorectal cancer, and endocrine cancers.
- Analyze and explain payment reform and quality as applied to cancer care.
- Discern and apply novel techniques in cancer surgery.
||The Society of Surgical Oncology (SSO) is accredited by the Accreditation Council for Continuing
Medical Education (ACCME) to provide continuing medical education for physicians.
The Society of Surgical Oncology (SSO) designates this live activity for 21.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME/Certificate of Attendance
Please ensure to claim your CME certificate or certificate of participation by May 31, 2020.
Information on how to claim credit will be added at a later date.
The primary purpose of the SSO Annual Cancer Symposium is educational. Information, as well as technologies, products and/or services discussed, are intended to inform participants about the knowledge, techniques and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exists in the specialty and the SSO disclaims any and all liability for damages to any individual attending this conference and for all claims which may result from the use of information, technologies, products and/or services discussed at the conference.